BOT 4.17% 37.5¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-860

  1. 2,505 Posts.
    lightbulb Created with Sketch. 546
    stupidly undervalued...1801 has de- risked co a lot...

    we knew it should work...and it worked...Excellent results ...endpoints met..

    should be stilling at least at over 40c...with more developments to come this year ...Ph3..Roscea..Ph2b for 1801...
    non dilutive funding..

    yumi
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.015(4.17%)
Mkt cap ! $590.6M
Open High Low Value Volume
36.5¢ 40.0¢ 36.5¢ $10.56M 27.45M

Buyers (Bids)

No. Vol. Price($)
7 75348 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 514698 3
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.